| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT07326709 A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants… |
Trial sites expanded: 13 -> 20 locations |
| 2026-06-06 | NCT06868212 A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in… |
Trial sites expanded: 114 -> 128 locations |
| 2026-06-02 | NCT07225504 A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive… |
Trial sites expanded: 200 -> 208 locations |
| 2026-06-02 | NCT06744920 A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus… |
Trial sites expanded: 101 -> 129 locations |
| 2026-05-30 | NCT05156281 Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With… |
date change Primary completion pushed: 2026-04-30 -> 2026-07-23 |
| 2026-05-30 | NCT05147220 Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With… |
date change Primary completion pushed: 2026-04-30 -> 2026-07-23 |
| 2026-05-28 | NCT07225504 A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive… |
Trial sites expanded: 187 -> 200 locations |
| 2026-05-20 | NCT07225504 A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive… |
Trial sites expanded: 180 -> 187 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06744920 | A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus… | Generalized Myasthenia Gravis | Recruiting |
| NCT07225504 | A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive… | Secondary Progressive Multiple Sclerosis (SPMS) | Recruiting |
| NCT07456891 | Remibrutinib Open Label Roll-over Post-trial Access Protocol | Indication of the Parent Protocol | Recruiting |
| NCT05677451 | 24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK… | Chronic Spontaneous Urticaria | Recruiting |
| NCT06868212 | A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in… | Chronic Spontaneous Urticaria (CSU) | Recruiting |
| NCT07326709 | A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants… | Huntington Disease | Recruiting |
| NCT05513001 | An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in… | Chronic Spontaneous Urticaria | Active, Not Recruiting |
| NCT05147220 | Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With… | Relapsing Multiple Sclerosis | Active, Not Recruiting |
| NCT05156281 | Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With… | Relapsing Multiple Sclerosis | Active, Not Recruiting |
| NCT06042478 | Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in… | Chronic Spontaneous Urticaria | Active, Not Recruiting |
| NCT05976243 | A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With… | Chronic Inducible Urticaria | Active, Not Recruiting |
| Phase 2 | |||
| NCT06865651 | Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of… | Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU) | Recruiting |
| NCT03827798 | Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to… | Hidradenitis Suppurativa | Active, Not Recruiting |
| NCT07222956 | A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS | Multiple Sclerosis (MS) - Relapsing-remitting | Not Yet Recruiting |